These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

230 related articles for article (PubMed ID: 1616860)

  • 21. Coordinated expression of oestrogen and androgen receptors in HER2-positive breast carcinomas: impact on proliferative activity.
    Lin Fde M; Pincerato KM; Bacchi CE; Baracat EC; Carvalho FM
    J Clin Pathol; 2012 Jan; 65(1):64-8. PubMed ID: 22039288
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Close correlation between progesterone receptor concentration and hormonal sensitivity in DMBA-induced mammary tumours of the rat.
    Mobbs BG
    Eur J Cancer Clin Oncol; 1983 Jun; 19(6):835-42. PubMed ID: 6409617
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Immunohistochemical determination of androgen receptors in relation to oestrogen and progesterone receptors in female breast cancer.
    Kuenen-Boumeester V; Van der Kwast TH; van Putten WL; Claassen C; van Ooijen B; Henzen-Logmans SC
    Int J Cancer; 1992 Oct; 52(4):581-4. PubMed ID: 1399140
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Clinicopathologic Characteristics of Oestrogen Receptor-Positive/Progesterone Receptor-Negative/Her2-Negative Breast Cancer According to a Novel Definition of Negative Progesterone Receptor Status: A Large Population-Based Study from China.
    Li AQ; Zhou SL; Li M; Xu Y; Shui RH; Yu BH; Yang WT
    PLoS One; 2015; 10(5):e0125067. PubMed ID: 25938238
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Immunohistochemical determination of estrogen and progesterone receptors in breast cancer: relationship with clinicopathologic factors in 302 patients in Ivory Coast.
    Effi AB; Aman NA; Koui BS; Koffi KD; Traoré ZC; Kouyate M
    BMC Cancer; 2017 Feb; 17(1):115. PubMed ID: 28173783
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Quantitative fluorescence cytometric measurement of estrogen and progesterone receptors: correlation with the hormone binding assay.
    Gritzapis AD; Baxevanis CN; Missitzis I; Katsanou ES; Alexis MN; Yotis J; Papamichail M
    Breast Cancer Res Treat; 2003 Jul; 80(1):1-13. PubMed ID: 12889594
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Improved method for assay of estradiol and progesterone receptors with special reference to breast cancer.
    Norgren A; Borg A; Fernö M; Johansson U; Lindahl B; Tsiobanelis K
    Anticancer Res; 1982; 2(5):315-20. PubMed ID: 6187272
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Comparative study of estrogen receptor assays between immunocytochemical assay using monoclonal antibody and the dextran- coated charcoal method].
    Toi M; Hamada Y; Seto Y; Hisamatsu K; Suehiro S; Toge T; Niimoto M; Hattori T
    Gan To Kagaku Ryoho; 1986 Oct; 13(10):3056-62. PubMed ID: 2429620
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Expression of steroid receptors in acoustic neuroma.
    Filipo R; Petrangeli E; Monini S; Ortolani F; Gulino A; Barbara M; Frati L
    Clin Otolaryngol Allied Sci; 1995 Oct; 20(5):413-7. PubMed ID: 8582072
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Oestrogen and progesterone receptors in human term placenta. Measurement by binding assays and immunological methods.
    Rivera J; Cano A
    Placenta; 1989; 10(6):579-88. PubMed ID: 2608640
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Study of estrogen receptor, progesterone receptor, and the estrogen-regulated Mr 24,000 protein in patients with carcinomas of the endometrium and cervix.
    Ciocca DR; Puy LA; Fasoli LC
    Cancer Res; 1989 Aug; 49(15):4298-304. PubMed ID: 2743317
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Comparison of immunohistochemical and biochemical assay of steroid receptors in primary breast cancer--clinical associations and reasons for discrepancies.
    Chebil G; Bendahl PO; Idvall I; Fernö M
    Acta Oncol; 2003; 42(7):719-25. PubMed ID: 14690157
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Prognostic value of estrogen and progesterone receptors measured by enzyme immunoassays in human breast tumor cytosols.
    Foekens JA; Portengen H; van Putten WL; Peters HA; Krijnen HL; Alexieva-Figusch J; Klijn JG
    Cancer Res; 1989 Nov; 49(21):5823-8. PubMed ID: 2676151
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Comparison of an immunocytochemical assay for progesterone receptor with a biochemical method of measurement and immunocytochemical examination of the relationship between progesterone and estrogen receptors.
    Berger U; Wilson P; Thethi S; McClelland RA; Greene GL; Coombes RC
    Cancer Res; 1989 Sep; 49(18):5176-9. PubMed ID: 2766287
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Regulation of estrogen and progestin receptor concentrations in an experimental rat prostatic carcinoma by estrogen, antiestrogen, and progesterone.
    Mobbs BG; Johnson IE; DeSombre ER; Toth J; Hughes A
    Cancer Res; 1987 May; 47(10):2645-51. PubMed ID: 3552202
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Quantitative assessment of oestrogen and progesterone receptors on fine-needle aspirates and cryostat sections of breast carcinomas: how does this compare with biochemical assays?
    Muchiri LW
    East Afr Med J; 1993 May; 70(5):280-3. PubMed ID: 8306903
    [TBL] [Abstract][Full Text] [Related]  

  • 37. High expression of progesterone receptor may be an adverse prognostic factor in oestrogen receptor-negative/progesterone receptor-positive breast cancer: results of comprehensive re-evaluation of multi-institutional case series.
    Kunc M; Pęksa R; Cserni G; Iżycka-Świeszewska E; Łacko A; Radecka B; Braun M; Pikiel J; Litwiniuk M; Pogoda K; Szwajkosz A; Biernat W; Senkus E
    Pathology; 2022 Apr; 54(3):269-278. PubMed ID: 35074178
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Downregulation of nuclear expression of the p33(ING1b) inhibitor of growth protein in invasive carcinoma of the breast.
    Nouman GS; Anderson JJ; Crosier S; Shrimankar J; Lunec J; Angus B
    J Clin Pathol; 2003 Jul; 56(7):507-11. PubMed ID: 12835295
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Immunocytochemical estrogen and progestin receptor assays in breast cancer with monoclonal antibodies. Histopathologic, demographic, and biochemical correlations and relationship to endocrine response and survival.
    Pertschuk LP; Kim DS; Nayer K; Feldman JG; Eisenberg KB; Carter AC; Rong ZT; Thelmo WL; Fleisher J; Greene GL
    Cancer; 1990 Oct; 66(8):1663-70. PubMed ID: 2208020
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Immunohistochemical and biochemical analysis of the oestrogen regulated protein pS2, and its relation with oestrogen receptor and progesterone receptor in breast cancer.
    Detre S; King N; Salter J; MacLennan K; McKinna JA; Dowsett M
    J Clin Pathol; 1994 Mar; 47(3):240-4. PubMed ID: 8163696
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.